BONASO, MARCO Statistiche
BONASO, MARCO
DIPARTIMENTO DI BIOLOGIA
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy
2024-01-01 da Silva Machado, Fernanda Lacerda; Cañás, Martín; Urtasun, Martín A.; Marín, Gustavo H.; Albuquerque, Flavia Caixeta; Pont, Lisa; Convertino, Irma; Bonaso, Marco; Tuccori, Marco; Kirchmayer, Ursula; Lopes, Luciane Cruz
Communicating Drug Safety
2024-01-01 Tuccori, Marco; Convertino, Irma; Ferraro, Sara; Bonaso, Marco; Valdiserra, Giulia; Cappello, Emiliano
Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience
2024-01-01 Di Paolo, M; Maiese, A; Scatena, A; Bonaso, M; Marcacci, I; Convertino, I; Occhipinti, C; Pieretti, R; Tuccori, M
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option
2024-01-01 Ferraro, Sara; Convertino, Irma; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Tuccori, Marco
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project
2023-01-01 Valdiserra, G; Cappello, E; Bonaso, M; Ferraro, S; Convertino, I; Crescioli, G; Lombardi, N; Tuccori, M
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy
2023-01-01 Convertino, I.; Cazzato, M.; Tillati, S.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bonaso, M.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M.
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison
2023-01-01 Machado, F. L. D. S.; Canas, M.; Doubova, S. V.; Urtasun, M. A.; Marin, G. H.; Osorio-de-Castro, C. G. S.; Albuquerque, F. C.; Ribeiro, T. B.; Pont, L.; Crisostomo Landeros, J.; Roldan Saelzer, J.; Sepulveda Viveros, D.; Acosta, A.; Machado Beltran, M. A.; Gordillo Alas, L. I.; Orellana Tablas, L. A.; Benko, R.; Convertino, I.; Bonaso, M.; Tuccori, M.; Kirchmayer, U.; Contreras Sanchez, S. E.; Rodriguez-Tanta, L. Y.; Gutierrez Aures, Y.; Lin, B.; Alipour-Haris, G.; Eworuke, E.; Lopes, L. C.
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis
2023-01-01 Convertino, I; Lucenteforte, E; Arzenton, E; Giometto, S; De Luca, G; Malanima, M; Ferraro, S; Bonaso, M; Cappello, E; Valdiserra, G; Cazzato, M; Moretti, U; Mosca, M; Gini, R; Tuccori, M
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database.
2023-01-01 Cappello, E; Valdiserra, G; Bonaso, M; Ferraro, S; Convertino, I; Flaccavento, A; Tuccori, M
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
2023-01-01 Convertino, I.; Lorenzoni, V.; Gini, R.; Turchetti, G.; Fini, E.; Giometto, S.; Bartolini, C.; Paoletti, O.; Ferraro, S.; Cappello, E.; Valdiserra, G.; Bonaso, M.; Blandizzi, C.; Tuccori, M.; Lucenteforte, E.
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x)
2023-01-01 Cappello, E.; Valdiserra, G.; Bonaso, M.; Ferraro, S.; Convertino, I.; Tuccori, M.
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error.
2023-01-01 Bonaso, M; Cappello, E; Convertino, I; Ferraro, S; Valdiserra, G; Tuccori, M
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase
2023-01-01 Valdiserra, G; Cappello, E; Ferraro, S; Convertino, I; Bonaso, M; Moretti, U; Tuccori, M
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring
2023-01-01 Cappello, E; Valdiserra, G; Bonaso, M; Convertino, I; Ferraro, S; Tuccori, M
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence
2023-01-01 Convertino, Irma; Ferraro, Sara; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Tuccori, Marco
A regulatory overview of biosimilars across selected countries
2022-01-01 Lopes, Luciane; Santos, Gustavo M.; Doubova, Svetlana; Pont, Lisa; Eworuke, Efe; Canas, Martin; Tuccori, Marco; Gordillo Alas, Lily Iracema; Acosta Santamaria, Angela; Marin, Gustavo H.; Ostomo Landeros, Jose Cris; Albuquerque, Flavia C.; Alipour Haris, Golnoosh; Urtasun, Martin A.; Lin, Boya; Roldan-Saelzer, Juan; Carmona-Sepulveda, Patricia; Viveros, Dino; Vera, Felipe D.; Convertino, Irma; Bonaso, Marco; Serpa Osorio-de-Castro, Claudia Garcia; Kirchmayer, Ursula; Falcao, Mariama G.; Machado, Fernanda Lacerda L.; Orellana Tablas, Lourdes Abigail; Contreras Sanchez, Saul Eduardo; Machado Beltran, Manuel
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database
2022-01-01 Bonaso, M.; Marchione, P.; Felicetti, P.; Petronzelli, F.; Cappello, E.; Samez, S.; Zappetti, C.; Rossi, P.; Merlano, C.; Valdiserra, G.; Ferraro, S.; Convertino, I.; Marra, A. R.; Parrilli, M.; Tuccori, M.
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study
2022-01-01 Ferraro, Sara; Paoletti, Olga; Giometto, Sabrina; Tillati, Silvia; Convertino, Irma; Valdiserra, Giulia; Cappello, Emiliano; Bonaso, Marco; Bartolini, Claudia C.; Lorenzoni, Valentina; Turchetti, Giuseppe; Gini, Rosa; Fornai, Matteo; Lucenteforte, Ersilia; Tuccori, Marco
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients
2022-01-01 Convertino, Irma; Cazzato, Massimiliano; Tillati, Silvia; Giometto, Sabrina; Gini, Rosa; Valdiserra, Giulia; Cappello, Emiliano; Ferraro, Sara; Bonaso, Marco; Bartolini, Claudia C.; Paoletti, Olga; Lorenzoni, Valentina; Filippi, Matteo; Turchetti, Giuseppe; Cristofano, Michele; Blandizzi, Corrado; Mosca, Marta; Lucenteforte, Ersilia; Tuccori, Marco
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World
2022-01-01 Bonaso, M.; Moretti, U.; Valdiserra, G.; Cappello, E.; Convertino, I.; Ferraro, S.; Tuccori, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy | 1-gen-2024 | da Silva Machado, Fernanda Lacerda; Cañás, Martín; Urtasun, Martín A.; Marín, Gustavo H.; Albuquerque, Flavia Caixeta; Pont, Lisa; Convertino, Irma; Bonaso, Marco; Tuccori, Marco; Kirchmayer, Ursula; Lopes, Luciane Cruz | |
| Communicating Drug Safety | 1-gen-2024 | Tuccori, Marco; Convertino, Irma; Ferraro, Sara; Bonaso, Marco; Valdiserra, Giulia; Cappello, Emiliano | |
| Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience | 1-gen-2024 | Di Paolo, M; Maiese, A; Scatena, A; Bonaso, M; Marcacci, I; Convertino, I; Occhipinti, C; Pieretti, R; Tuccori, M | |
| Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option | 1-gen-2024 | Ferraro, Sara; Convertino, Irma; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Tuccori, Marco | |
| Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project | 1-gen-2023 | Valdiserra, G; Cappello, E; Bonaso, M; Ferraro, S; Convertino, I; Crescioli, G; Lombardi, N; Tuccori, M | |
| Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy | 1-gen-2023 | Convertino, I.; Cazzato, M.; Tillati, S.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bonaso, M.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M. | |
| Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison | 1-gen-2023 | Machado, F. L. D. S.; Canas, M.; Doubova, S. V.; Urtasun, M. A.; Marin, G. H.; Osorio-de-Castro, C. G. S.; Albuquerque, F. C.; Ribeiro, T. B.; Pont, L.; Crisostomo Landeros, J.; Roldan Saelzer, J.; Sepulveda Viveros, D.; Acosta, A.; Machado Beltran, M. A.; Gordillo Alas, L. I.; Orellana Tablas, L. A.; Benko, R.; Convertino, I.; Bonaso, M.; Tuccori, M.; Kirchmayer, U.; Contreras Sanchez, S. E.; Rodriguez-Tanta, L. Y.; Gutierrez Aures, Y.; Lin, B.; Alipour-Haris, G.; Eworuke, E.; Lopes, L. C. | |
| Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis | 1-gen-2023 | Convertino, I; Lucenteforte, E; Arzenton, E; Giometto, S; De Luca, G; Malanima, M; Ferraro, S; Bonaso, M; Cappello, E; Valdiserra, G; Cazzato, M; Moretti, U; Mosca, M; Gini, R; Tuccori, M | |
| Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. | 1-gen-2023 | Cappello, E; Valdiserra, G; Bonaso, M; Ferraro, S; Convertino, I; Flaccavento, A; Tuccori, M | |
| Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis | 1-gen-2023 | Convertino, I.; Lorenzoni, V.; Gini, R.; Turchetti, G.; Fini, E.; Giometto, S.; Bartolini, C.; Paoletti, O.; Ferraro, S.; Cappello, E.; Valdiserra, G.; Bonaso, M.; Blandizzi, C.; Tuccori, M.; Lucenteforte, E. | |
| Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) | 1-gen-2023 | Cappello, E.; Valdiserra, G.; Bonaso, M.; Ferraro, S.; Convertino, I.; Tuccori, M. | |
| Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. | 1-gen-2023 | Bonaso, M; Cappello, E; Convertino, I; Ferraro, S; Valdiserra, G; Tuccori, M | |
| Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase | 1-gen-2023 | Valdiserra, G; Cappello, E; Ferraro, S; Convertino, I; Bonaso, M; Moretti, U; Tuccori, M | |
| Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring | 1-gen-2023 | Cappello, E; Valdiserra, G; Bonaso, M; Convertino, I; Ferraro, S; Tuccori, M | |
| Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence | 1-gen-2023 | Convertino, Irma; Ferraro, Sara; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Tuccori, Marco | |
| A regulatory overview of biosimilars across selected countries | 1-gen-2022 | Lopes, Luciane; Santos, Gustavo M.; Doubova, Svetlana; Pont, Lisa; Eworuke, Efe; Canas, Martin; Tuccori, Marco; Gordillo Alas, Lily Iracema; Acosta Santamaria, Angela; Marin, Gustavo H.; Ostomo Landeros, Jose Cris; Albuquerque, Flavia C.; Alipour Haris, Golnoosh; Urtasun, Martin A.; Lin, Boya; Roldan-Saelzer, Juan; Carmona-Sepulveda, Patricia; Viveros, Dino; Vera, Felipe D.; Convertino, Irma; Bonaso, Marco; Serpa Osorio-de-Castro, Claudia Garcia; Kirchmayer, Ursula; Falcao, Mariama G.; Machado, Fernanda Lacerda L.; Orellana Tablas, Lourdes Abigail; Contreras Sanchez, Saul Eduardo; Machado Beltran, Manuel | |
| COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database | 1-gen-2022 | Bonaso, M.; Marchione, P.; Felicetti, P.; Petronzelli, F.; Cappello, E.; Samez, S.; Zappetti, C.; Rossi, P.; Merlano, C.; Valdiserra, G.; Ferraro, S.; Convertino, I.; Marra, A. R.; Parrilli, M.; Tuccori, M. | |
| Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study | 1-gen-2022 | Ferraro, Sara; Paoletti, Olga; Giometto, Sabrina; Tillati, Silvia; Convertino, Irma; Valdiserra, Giulia; Cappello, Emiliano; Bonaso, Marco; Bartolini, Claudia C.; Lorenzoni, Valentina; Turchetti, Giuseppe; Gini, Rosa; Fornai, Matteo; Lucenteforte, Ersilia; Tuccori, Marco | |
| Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients | 1-gen-2022 | Convertino, Irma; Cazzato, Massimiliano; Tillati, Silvia; Giometto, Sabrina; Gini, Rosa; Valdiserra, Giulia; Cappello, Emiliano; Ferraro, Sara; Bonaso, Marco; Bartolini, Claudia C.; Paoletti, Olga; Lorenzoni, Valentina; Filippi, Matteo; Turchetti, Giuseppe; Cristofano, Michele; Blandizzi, Corrado; Mosca, Marta; Lucenteforte, Ersilia; Tuccori, Marco | |
| Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World | 1-gen-2022 | Bonaso, M.; Moretti, U.; Valdiserra, G.; Cappello, E.; Convertino, I.; Ferraro, S.; Tuccori, M. |